Viewing Study NCT05682859


Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2026-01-24 @ 11:37 PM
Study NCT ID: NCT05682859
Status: RECRUITING
Last Update Posted: 2023-11-18
First Post: 2022-12-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)
Sponsor: Jacob Pontoppidan Thyssen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hand Eczema View
Keywords: